Neoplasm related pain (acute) (chronic)
ICD-10 G89.3 is a billable code used to indicate a diagnosis of neoplasm related pain (acute) (chronic).
Neoplasm related pain (acute) (chronic) refers to pain that is directly associated with the presence of a neoplasm, which can be benign or malignant. This pain can manifest as either acute or chronic, depending on the duration and underlying causes. Acute pain typically arises suddenly and is often linked to the tumor's growth, pressure on surrounding tissues, or treatment-related effects. Chronic pain, on the other hand, persists over time and may result from ongoing tumor activity, nerve damage, or the long-term effects of cancer treatments such as chemotherapy or radiation. Patients may experience a variety of pain syndromes, including neuropathic pain, which can be exacerbated by autonomic disorders or complications such as hydrocephalus. Accurate coding of neoplasm-related pain is crucial for appropriate treatment planning and reimbursement, as it reflects the complexity of managing pain in patients with cancer.
Detailed documentation of the neoplasm type, stage, and treatment history is essential.
Patients experiencing pain due to tumor growth or treatment side effects.
Consideration of pain management strategies and their effectiveness.
Comprehensive pain assessments and treatment plans must be documented.
Management of chronic pain in cancer patients, including medication adjustments.
Coordination with oncology for integrated care.
Used for follow-up visits to manage neoplasm-related pain.
Document the patient's pain level, treatment response, and any changes in management.
Oncology and pain management specialists should collaborate on documentation.
G89.3 should be used when documenting pain that is directly related to a neoplasm, whether acute or chronic, and must be supported by clear clinical documentation.
